Shopping Cart
- Remove All
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $882 | 10-14 weeks | |
50 mg | $1,170 | 10-14 weeks | |
100 mg | $1,770 | 10-14 weeks |
Description | KU 59403 is a selective and potent ATM inhibitor with antitumor and anticancer activity, inhibits ATM, DNA-PK and PI3K, and is often used in combination therapy with PARP or ATR inhibitors to slow the progression of cancer. |
In vitro | In LoVo, HCT116, and SW620, U2OS, and MDA-MB-231 cells, KU 59403 (1 μM; 16 hours) exhibited at least 1000-fold specificity for ATM over other tested members of the PI3K family[1]. |
In vivo | In CD-1 nude mice implanted with SW620 or HCT116-N7 human cancer cell lines at 1×107 cells per animal subcutaneously, KU 59403 (6, 12.5, and 25 mg/kg; intraperitoneal administration twice daily (0 and 4 hours) and 12.5 mg/kg once daily) alone caused a modest tumor growth delay of 4 days (time to RTV4 = 10.5 days)[1]. |
Alias | KU-59403, KU59403 |
Molecular Weight | 564.72 |
Formula | C29H32N4O4S2 |
Cas No. | 845932-30-1 |
Storage | store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year | |||||||||||||||
Solubility Information | DMSO: 5 mg/mL (8.86 mM) | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.